UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)

Annals of oncology, 2013-10, Vol.24 (10), p.2672-2676

2013

Volltextzugriff (PDF)

EP-1158: Should breathing adapted radiation therapy also be applied for right-sided breast irradiation?

Radiotherapy and oncology, 2016-04, Vol.119, p.S552-S553

2016

Volltextzugriff (PDF)

EP-1159: Does a SPECT-CT improve the delineation of internal mammary nodes for breast cancer patients?

Radiotherapy and oncology, 2016-04, Vol.119, p.S553-S553

2016

Volltextzugriff (PDF)

SP-0561: ESTRO guideline for delineation of lymph node regions in breast cancer

Radiotherapy and oncology, 2014, Vol.111, p.S219-S219

2014

Volltextzugriff (PDF)

EP-1630: Automated iterative plan optimisation widens therapeutic window for prostate cancer arc therapy

Radiotherapy and oncology, 2016-04, Vol.119, p.S760-S760

2016

Volltextzugriff (PDF)

OC-0152: Influence of SIB, hypofractionation and oncoplastic surgery on cosmetic outcome in breast cancer

Radiotherapy and oncology, 2014, Vol.111, p.S58-S58

2014

Volltextzugriff (PDF)

Author Comment on: Álvarez B, Montero Á, Aramburu F, Calvo E, Ángel de la Casa M, Valero J, et al. Radiotherapy for ostheoarticular degenerative disorders: When nothing else works. Osteoarthritis and Cartilage Open. 2019:100016

Osteoarthritis and cartilage open, 2020-03, Vol.2 (1), p.100041-100041, Article 100041

2020

Volltextzugriff (PDF)

OC-0389: The influence of the boost dose on cosmetic outcome after breast conserving therapy: results of the Young Boost Trial

Radiotherapy and oncology, 2015-04, Vol.115, p.S187-S187

2015

Volltextzugriff (PDF)

OC-0488: 17 year results of the randomized boost versus no boost EORTC 22881-10882 trial in early breast cancer

Radiotherapy and oncology, 2014, Vol.111, p.S190-S191

2014

Volltextzugriff (PDF)

Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S70-S71

2012

Volltextzugriff (PDF)

Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial

Annals of oncology, 2012-10, Vol.23 (10), p.2591-2598

2012

Volltextzugriff (PDF)

Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past and the Present

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-08, Vol.34 (8), p.537-544

2022

Volltextzugriff (PDF)

The influence of the boost dose on cosmetic outcome after breast conserving therapy: Results of the Young Boost Trial

European journal of cancer (1990), 2018-04, Vol.92, p.S9

2018

Volltextzugriff (PDF)

5 - The influence of the boost dose on cosmetic outcome after breast conserving therapy: Results of the Young Boost Trial

European journal of cancer (1990), 2018-04, Vol.92, p.S9-S9

2018

Volltextzugriff (PDF)

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands

Annals of oncology, 2014-01, Vol.25 (1), p.64-68

2014

Volltextzugriff (PDF)

The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S2-S3

2007

Volltextzugriff (PDF)

Low-dose radiation therapy as treatment for hand and knee osteoarthritis: two double-blinded RCT'S

Osteoarthritis and cartilage, 2018-04, Vol.26, p.S329-S330

2018

Volltextzugriff (PDF)

OC-0568: Accelerated PBI VS standard radiotherapy (IRMA trial): interim cosmetic and toxicity results

Radiotherapy and oncology, 2017-05, Vol.123, p.S303-S303

2017

Volltextzugriff (PDF)

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial

European journal of cancer supplements, 2008, Vol.6 (7), p.132-133

2008

Volltextzugriff (PDF)

Long-term cosmetic changes after breast conserving therapy for patients with stage I and II breast cancer treated in the EORTC “boost versus no boost” trial

European journal of cancer supplements, 2008, Vol.6 (7), p.134-134

2008

Volltextzugriff (PDF)

O-113 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial

European journal of cancer supplements, 2007, Vol.5 (3), p.34-34

2007

Volltextzugriff (PDF)

Adjuvant locoregional radiotherapy

European journal of cancer supplements, 2004-03, Vol.2 (3), p.64-65

Poortmans, P.M

2004

Volltextzugriff (PDF)

The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts

European Journal of Cancer, 2003-03, Vol.39 (4), p.430-437

2003

Volltextzugriff (PDF)

Using loco-regional recurrence as an indicator of the quality of breast cancer treatment

European journal of cancer (1990), 2004-03, Vol.40 (4), p.487-493

2004

Volltextzugriff (PDF)

The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future

European journal of surgical oncology, 2005-08, Vol.31 (6), p.667-674

2005

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaCombined Modality Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(37)
Tagungsberichte
(1)

Sprache

Englisch
(38)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(13)
Science & Technology
(10)
Life Sciences & Biomedicine
(9)
Oncology
(9)
Humans
(7)
Female
(5)
Biological And Medical Sciences
(4)
Breast Cancer
(4)
Medical Sciences
(4)
Middle Aged
(4)
Radiotherapy
(4)
Tumors
(4)
Adult
(3)
Aged
(3)
Antineoplastic Agents
(3)
Pharmacology. Drug Treatments
(3)
Survival Analysis
(3)
Young Adult
(3)
Adolescent
(2)
Breast Neoplasms - Surgery
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)

EP-1158: Should breathing adapted radiation therapy also be applied for right-sided breast irradiation?

EP-1159: Does a SPECT-CT improve the delineation of internal mammary nodes for breast cancer patients?

SP-0561: ESTRO guideline for delineation of lymph node regions in breast cancer

EP-1630: Automated iterative plan optimisation widens therapeutic window for prostate cancer arc therapy

OC-0152: Influence of SIB, hypofractionation and oncoplastic surgery on cosmetic outcome in breast cancer

Author Comment on: Álvarez B, Montero Á, Aramburu F, Calvo E, Ángel de la Casa M, Valero J, et al. Radiotherapy for ostheoarticular degenerative disorders: When nothing else works. Osteoarthritis and Cartilage Open. 2019:100016

OC-0389: The influence of the boost dose on cosmetic outcome after breast conserving therapy: results of the Young Boost Trial

OC-0488: 17 year results of the randomized boost versus no boost EORTC 22881-10882 trial in early breast cancer

Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment

Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial

Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past and the Present

The influence of the boost dose on cosmetic outcome after breast conserving therapy: Results of the Young Boost Trial

5 - The influence of the boost dose on cosmetic outcome after breast conserving therapy: Results of the Young Boost Trial

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands

The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial

Low-dose radiation therapy as treatment for hand and knee osteoarthritis: two double-blinded RCT'S

OC-0568: Accelerated PBI VS standard radiotherapy (IRMA trial): interim cosmetic and toxicity results

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial

Long-term cosmetic changes after breast conserving therapy for patients with stage I and II breast cancer treated in the EORTC “boost versus no boost” trial

O-113 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial

Adjuvant locoregional radiotherapy

The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts

Using loco-regional recurrence as an indicator of the quality of breast cancer treatment

The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future

Aktive Filter

Suchergebnisse filtern